• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Pacific Biosciences

edit

Pacifc Biosciences is a startup biotechnology company developing a transformative Single Molecule Real Time (SMRT) DNA sequencing platform. PacBio’s goal is to commercialize SMRT DNA sequencing technology, eventually enabling sequencing of individual genomes as part of routine medical care.

Milestones

edit

• 
  Went public with stock symbol NASDAQ:PACB.
  Posted 10/26/10 at 10:52pm
• 
  Pacific Biosciences received $7.72M in Series C funding. (8/31/05)
  Posted 7/4/10 at 11:47pm
• 
  Pacific Biosciences received $109M in Series F funding. (7/14/10)
  Posted 6/20/10 at 3:13am via fiercebiotech.com
• 
  Pacific Biosciences received $50M in Series D funding. (1/15/07)
  Posted 9/17/09 at 2:07am via venturebeat.com
• 
  Pacific Biosciences received $68M in Series E funding. (10/1/09)
  Posted 8/13/09 at 11:54am via onbiovc.com
• 
  Pacific Biosciences — Pacific Biosciences Announces Pricing of Initial Public Offering of Common Stock (10/26/10)
  Posted 10/26/10 at 10:53pm via pacificbiosciences.com

Videos

Screenshots

edit

Stock Price

Sources

1. Cap Funding Report [edit]
2. DNA health company Pacific Biosciences raises $50M from Kleiner, others (deals.venturebeat.com) [edit]
3. Pacific Biosciences, Inc.: Series E $68M (onbiovc.com) [edit]
4. Pacific Biosciences adds $109M to its venture haul (fiercebiotech.com) [edit]
5. Pacific Biosciences Announces Pricing of Initial Public Offering of Common Stock (pacificbiosciences.com) [edit]